Fig. 3

Immunohistochemistry validation in ccRCC clinical specimens and para-carcinoma specimens. (A) Expression of SHC1 in para-carcinoma specimens of ccRCC patients. (B) Expression of SHC1 in ccRCC clinical tissues. Three antibodies (HPA001844, CAB005374, CAB016305) were applied. Scale bar = 200 µm.